Immix Biopharma, Inc.
Immix Biopharma, Inc. (IMMX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · IMMX · as of Jun 8, 2026
Key Statistics
Explore Immix Biopharma, Inc. Data
immx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 100.0%
The IMMX analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +116.01% upside from the current price of $7.87.
Competitors & Peers
immx competitorsIMMX
ATOS
COYA
MGNX
ONCY
ORMPStock Performance
Full HistoryAbout Immix Biopharma, Inc.
Immix Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to creating a range of tissue-specific therapies. Operating in both the United States and Australia, their primary focus areas ar…
what is immix biopharma, inc. · immx stock overview · immix biopharma, inc. company profile · who is immix biopharma, inc. ceo · immx NASDAQ · immix biopharma, inc. headquarters · immix biopharma, inc. business segments
About Stock Overview & Key Data
Immix Biopharma, Inc. (IMMX) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Dec 16, 2021. As of the latest trading session, IMMX stock price is $7.87, with a market capitalization of $428.2M. The stock has returned +236.32% over the past 12 months and +50.48% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Immix Biopharma, Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Immix Biopharma, Inc. reported revenue of — and net income of -$29.4M. For detailed data — including Immix Biopharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Immix Biopharma, Inc. (IMMX) stock price is $7.87. The stock is traded on NASDAQ under the ticker symbol IMMX. The 52-week range is $1.94 – $11.61.